Viridian Therapeutics Statistics
Total Valuation
VRDN has a market cap or net worth of $817.86 million. The enterprise value is $360.70 million.
| Market Cap | 817.86M |
| Enterprise Value | 360.70M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VRDN has 62.77 million shares outstanding. The number of shares has increased by 39.48% in one year.
| Shares Outstanding | 62.77M |
| Shares Change (YoY) | +39.48% |
| Shares Change (QoQ) | +14.19% |
| Owned by Insiders (%) | 1.02% |
| Owned by Institutions (%) | 101.06% |
| Float | 47.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,604.66 |
| Forward PS | 2,814.41 |
| PB Ratio | 1.85 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,148.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.27, with a Debt / Equity ratio of 0.05.
| Current Ratio | 18.27 |
| Quick Ratio | 17.93 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -127.71 |
Financial Efficiency
Return on equity (ROE) is -68.30% and return on invested capital (ROIC) is -55.05%.
| Return on Equity (ROE) | -68.30% |
| Return on Assets (ROA) | -61.10% |
| Return on Capital (ROIC) | -55.05% |
| Revenue Per Employee | $3,340 |
| Profits Per Employee | -$2.53M |
| Employee Count | 94 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.19% in the last 52 weeks. The beta is 1.10, so VRDN's price volatility has been similar to the market average.
| Beta (1Y) | 1.10 |
| 52-Week Price Change | -55.19% |
| 50-Day Moving Average | 17.42 |
| 200-Day Moving Average | 17.70 |
| Relative Strength Index (RSI) | 21.80 |
| Average Volume (30 Days) | 903,008 |
Short Selling Information
The latest short interest is 9.47 million, so 15.09% of the outstanding shares have been sold short.
| Short Interest | 9.47M |
| Short Previous Month | 7.62M |
| Short % of Shares Out | 15.09% |
| Short % of Float | 19.76% |
| Short Ratio (days to cover) | 8.29 |
Income Statement
In the last 12 months, VRDN had revenue of $314,000 and -$237.73 million in losses. Loss per share was -$5.31.
| Revenue | 314,000 |
| Gross Profit | 314,000 |
| Operating Income | -254.45M |
| Pretax Income | -237.73M |
| Net Income | -237.73M |
| EBITDA | -235.32M |
| EBIT | -235.89M |
| Loss Per Share | -$5.31 |
Balance Sheet
The company has $477.37 million in cash and $20.21 million in debt, giving a net cash position of $457.17 million or $7.28 per share.
| Cash & Cash Equivalents | 477.37M |
| Total Debt | 20.21M |
| Net Cash | 457.17M |
| Net Cash Per Share | $7.28 |
| Equity / Book Value | 442.02M |
| Book Value Per Share | 7.04 |
| Working Capital | 459.84M |
Cash Flow
In the last 12 months, operating cash flow was -$184.17 million and capital expenditures -$898,000, giving a free cash flow of -$185.07 million.
| Operating Cash Flow | -184.17M |
| Capital Expenditures | -898,000 |
| Free Cash Flow | -185.07M |
| FCF Per Share | -$4.14 |
Margins
Gross margin is 100.00%, with operating and profit margins of -81,035.03% and -75,711.46%.
| Gross Margin | 100.00% |
| Operating Margin | -81,035.03% |
| Pretax Margin | -75,711.46% |
| Profit Margin | -75,711.46% |
| EBITDA Margin | -74,941.72% |
| EBIT Margin | -75,123.25% |
| FCF Margin | -58,938.85% |
Dividends & Yields
VRDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.48% |
| Shareholder Yield | -39.48% |
| Earnings Yield | -29.07% |
| FCF Yield | -22.63% |
Analyst Forecast
The average price target for VRDN is $37.80, which is 190.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $37.80 |
| Price Target Difference | 190.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 401.77% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 13, 2020. It was a reverse split with a ratio of 1:15.
| Last Split Date | Nov 13, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
VRDN has an Altman Z-Score of 7.6 and a Piotroski F-Score of 2.
| Altman Z-Score | 7.6 |
| Piotroski F-Score | 2 |